Nr.Numele studiuluiStatusLocatia/Locatiile studiului
1EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX TreatmentIn curs de recrutareInstitutului Oncologic „Prof. Dr. Ion Chiricuţă”, Cluj-Napoca, Romania, Principal Investigator: Tudor Eliade Ciuleanu, MD         Medisprof SRL, Cluj, Romania, Principal Investigator: Adrian Udrea, MD         Oncolab, Craiova, Romania, Principal Investigator: Dan Stelian Lungulescu, MD         Sf Nectarie Oncology Center, Craiova, Romania, Principal Investigator: Michael Schenker, MD         Centrul de Oncologie Euroclinic, Iasi, Romania, Principal Investigator: Constantin Volovat, MD         Oncohelp, Timisoara, Romania, Principal Investigator: Serban Negru, MD      
 2Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer (PAC-MAIN)In curs de recrutareClinical Emergency Hospital Bucharest Recruiting Bucharest, Romania Contact: Vasile Sandru, MD    +0040728813095    drsandruvasile@gmail.com  
 3Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerIn curs de recrutareResearch Site Recruiting Bucharest, Romania, 022328 Research Site Recruiting Cluj-Napoca, Romania, 400015 Research Site Recruiting Cluj-Napoca, Romania, 400124 Research Site Recruiting Craiova, Romania, 200347 Research Site Recruiting Iasi, Romania, 700483 Research Site Recruiting Timisoara, Romania, 300239
(Visited 4 times, 1 visits today)